RxDoctor Payments Data

Joseph Rakestraw, DO

Family Medicine · Jefferson City, MONPI 1922002864

Payments from drug & device makers

$5,701in general payments, 2019–2025

Across 406 payments — averaging $14.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$522
  • Pfizer$389
  • AstraZeneca$299
  • Lilly USA, LLC$293
  • Astellas Pharma US Inc$213
  • plus $3K from 45 others

What the payments were for

  • Food & beverage$5,63099%
  • Education$711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,701 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$55,290
Medicare patients
228
Services billed
700

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide42$46,204
OzempicSemaglutide29$40,773
FarxigaDapagliflozin Propanediol51$38,746
EliquisApixaban90$38,702
CreonLipase/Protease/Amylase15$33,737
TrulicityDulaglutide14$23,343
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$22,167
JanuviaSitagliptin Phosphate16$21,213
Xtampza ErOxycodone Myristate13$20,324
Tresiba Flextouch U-100Insulin Degludec27$18,268
XareltoRivaroxaban22$13,342
SymbicortBudesonide/Formoterol Fumarate33$10,001
Lantus SolostarInsulin Glargine,hum.Rec.Anlog47$8,945
Fentanyl30$6,851
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen214$6,023

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$293$69,54756 claims
AstraZenecaFarxiga, Symbicort, Brilinta$299$52,21597 claims
PfizerEliquis, Premarin$389$41,133102 claims
Novo NordiskOzempic$522$40,77329 claims
AbbVieCreon$1,227$33,73715 claims
MerckJanuvia, Dulera$68$25,12327 claims
GSKTrelegy Ellipta$115$22,16729 claims
Collegium Pharmaceutical, Inc.Xtampza Er$12$20,32413 claims
Johnson & JohnsonXarelto$130$13,34222 claims
Sumitomo Pharma America, Inc.Gemtesa$54$5,36811 claims
Boehringer IngelheimStiolto Respimat$156$5,29111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Jefferson City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →